BF
PRCT icon

BOK Financial’s Procept Biorobotics PRCT Stock Holding History

BOK Financial’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,745
Closed -$626K – 1294
2025
Q1 		$626K Sell
10,745
-27
-0.3% -$1.84K 0.01% 512
2024
Q4 		$936K Buy
+10,772
New +$920K 0.02% 448

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

BOK Financial's PRCT Position: Q2 2025 in Review

BOK Financial sold out of Procept Biorobotics (PRCT) in Q2 2025, closing a stake of 10,745 shares — an estimated $626K sold.

BOK Financial first reported a position in PRCT in Q4 2024 and held it in 2 quarters. The position peaked at $936K in Q4 2024. 271 funds tracked by Wall St. Rank hold PRCT as of Q2 2025.

  • BOK Financial reported no remaining Procept Biorobotics position as of Q2 2025 after selling out during the quarter.
  • BOK Financial sold 10,745 Procept Biorobotics shares in Q2 2025, an estimated $626K.
  • BOK Financial first reported a position in Procept Biorobotics in Q4 2024 and held it in 2 quarters.
  • BOK Financial's Procept Biorobotics position peaked at $936K in Q4 2024.
  • 271 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2025.

Based on BOK Financial's 13F filing for Q2 2025, filed 12 Aug 2025.